Channel Avatar

Psychopharmacology Institute @[email protected]

None subscribers - no pronouns set

The Psychopharmacology Institute is an online platform offer


05:24
Unlocking the Power of Cannabidiol (CBD) for Psychiatric Disorders
05:37
In Utero Exposure to ADHD Medication and Long-Term Offspring Outcomes
04:52
Unlocking the Potential of N-Acetyl-Cysteine (NAC) for Mood Disorders: A Comprehensive Guide
09:08
Building Therapeutic Relationships: Psychodynamic Interventions and Their Impact
06:02
Risk of Irreversible Post‑SSRI Sexual Dysfunction with Antidepressants
07:01
Understanding Patient Ambivalence in Medical Treatment
08:13
Antipsychotics in the Treatment of Youth with Anorexia Nervosa
07:01
A Journey Into Psychodynamic Psychopharmacology
08:32
Tobacco Use, Nicotine Dependence, and Cessation Among Adults with Psychosis
11:02
Navigating the Complexities of Treatment Resistance
06:47
Relapse Prevention Strategies for Depression and Anxiety in Remitted Youth
04:50
A Comprehensive Guide to Treating Bipolar Disorder During Pregnancy
09:00
Zuranolone for the Treatment of Postpartum Depression
03:48
Understanding the Risks of Atypical Antipsychotics During Pregnancy
07:16
Use of Lithium in Pediatric Bipolar Disorders and Externalizing Childhood-Related Disorders
04:42
Managing Lithium in Pregnant Women With Bipolar Disorder
07:55
Use of NSAIDs for Delirium Risk Reduction
05:53
Understanding the Risks of Lithium Use in Pregnancy
06:20
Risk of Major Malformations Following First-Trimester Exposure to Olanzapine
09:25
The Role of Colony-Stimulating Factor in Clozapine Rechallenge Success
06:00
Clinical Cases Focusing on BSM Medication Usage
08:24
Age's Impact on Antidepressant Response
04:10
Practical Tips for Using BSMs in the Clinical Practice
09:44
Brexanolone's Impact on Postpartum Depression Symptoms
03:07
Broad-Spectrum Micronutrients and Drug Interactions
09:12
Adverse Effects of Antidepressant Medications in Youth
06:11
Broad-Spectrum Micronutrients: Safety and Tolerability
06:05
Mixed States: Exploring the 4 A's in Mood Disorders
06:51
Shifting Mood Disorder Treatment: From Categorical to Dimensional
05:06
Nonpharmacologic Therapies for Chronic Pain Management
07:46
ADHD and Co-Occurring Cannabis Use in Youth: An Emerging Clinical Challenge
03:44
Effective Pharmacologic Treatments for Fibromyalgia
04:29
Olanzapine/Samidorphan in Early-Stage Schizophrenia, Schizophreniform Disorder, and Bipolar I
02:47
Diagnosing Fibromyalgia and Understanding Nociplastic Pain
06:16
Metformin: A Solution for Antipsychotic-Related Weight Gain in Youth?
04:28
Efficacy, Safety, and Acceptability of Pimavanserin in Parkinson’s Disease Psychosis
11:13
Managing Cardiac and Metabolic Adverse Effects of Clozapine
06:18
Safety and Tolerability of Cariprazine in Pediatric Patients
11:28
Initiating and Optimizing Clozapine
04:45
Risk of Cardiovascular Diseases Associated With Medications Used in ADHD: A Systematic Review
05:27
Using Clozapine for Treatment Resistant Psychosis and Mood Disorders
07:05
Melatonin Use and the Risk of Self-Harm and Unintentional Injuries in Youth
06:03
Haloperidol for the Treatment of Delirium in ICU Patients
05:21
Pharmacogenomic Testing on Medication Selection and Remission in MDD
06:59
Management of Delirium in Patients With Cancer
08:50
Psychopharmacologic Treatment Algorithms for Bipolar Disorder in Youth
04:46
Treating Anxiety Disorders in Patients With Cancer
04:41
Antidepressants' Clinical Significance: Minimal Important Difference - Part 2
11:08
Treating Depressive Disorders in Patients With Cancer
06:17
Reported Side Effects Associated With Medication Nonadherence Among Youth With ADHD
06:21
Impact of Selected Initial Titration Schedules on Safety and Long-Term Effectiveness of Lamotrigine
08:21
Disparities in Pharmacologic Restraint Use in Pediatric Emergency Departments
09:26
Treatment Optimization for Tic Disorders
06:29
Associations Between Antipsychotic Use Substance Use and Relapse Risk in Patients with Schizophrenia
05:23
Risk of Cardiovascular Diseases Associated With Medications Used in ADHD
07:51
Tic Disorders and Psychiatric Comorbidities
04:09
Metformin for the Prevention of Clozapine-Induced Weight Gain: A Retrospective Cohort Study
06:27
Efficacy, Safety, and Tolerability of Ziprasidone in Youth
09:30
Understanding Tic Disorders
04:48
A Double-Blind Placebo-Controlled Study of Brexpiprazole for the Treatment of BPD